Structure

Physi-Chem Properties

Molecular Weight:  624.24
Volume:  597.818
LogP:  1.332
LogD:  0.564
LogS:  -2.647
# Rotatable Bonds:  13
TPSA:  221.9
# H-Bond Aceptor:  14
# H-Bond Donor:  7
# Rings:  4
# Heavy Atoms:  14

MedChem Properties

QED Drug-Likeness Score:  0.12
Synthetic Accessibility Score:  5.137
Fsp3:  0.6
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.204
MDCK Permeability:  9.671718726167455e-05
Pgp-inhibitor:  0.001
Pgp-substrate:  0.988
Human Intestinal Absorption (HIA):  0.746
20% Bioavailability (F20%):  0.05
30% Bioavailability (F30%):  0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.145
Plasma Protein Binding (PPB):  67.19387817382812%
Volume Distribution (VD):  0.362
Pgp-substrate:  18.577966690063477%

ADMET: Metabolism

CYP1A2-inhibitor:  0.034
CYP1A2-substrate:  0.013
CYP2C19-inhibitor:  0.013
CYP2C19-substrate:  0.066
CYP2C9-inhibitor:  0.013
CYP2C9-substrate:  0.044
CYP2D6-inhibitor:  0.007
CYP2D6-substrate:  0.064
CYP3A4-inhibitor:  0.15
CYP3A4-substrate:  0.103

ADMET: Excretion

Clearance (CL):  1.437
Half-life (T1/2):  0.915

ADMET: Toxicity

hERG Blockers:  0.128
Human Hepatotoxicity (H-HT):  0.253
Drug-inuced Liver Injury (DILI):  0.296
AMES Toxicity:  0.68
Rat Oral Acute Toxicity:  0.366
Maximum Recommended Daily Dose:  0.905
Skin Sensitization:  0.889
Carcinogencity:  0.875
Eye Corrosion:  0.003
Eye Irritation:  0.014
Respiratory Toxicity:  0.763

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC251062

Natural Product ID:  NPC251062
Common Name*:   Luzonoside A
IUPAC Name:   [(1S,4aS,6S,7R,7aS)-7-hydroxy-7-(hydroxymethyl)-6-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy-4-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-1-yl] 3-methylbutanoate
Synonyms:  
Standard InCHIKey:  VUZLGISBPIEZOX-HJBLAVRFSA-N
Standard InCHI:  InChI=1S/C30H40O14/c1-15(2)9-23(35)44-28-24-19(17(12-40-28)13-41-29-27(38)26(37)25(36)20(11-31)42-29)10-21(30(24,39)14-32)43-22(34)8-5-16-3-6-18(33)7-4-16/h3-8,12,15,19-21,24-29,31-33,36-39H,9-11,13-14H2,1-2H3/b8-5+/t19-,20-,21+,24-,25-,26+,27-,28+,29-,30-/m1/s1
SMILES:  CC(C)CC(=O)O[C@H]1[C@H]2[C@H](C[C@@H]([C@@]2(CO)O)OC(=O)/C=C/c2ccc(cc2)O)C(=CO1)CO[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL510787
PubChem CID:   11319570
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0002049] Terpene glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO8076 Viburnum luzonicum Species Adoxaceae Eukaryota n.a. n.a. n.a. PMID[15568771]
NPO8076 Viburnum luzonicum Species Adoxaceae Eukaryota n.a. leaf n.a. PMID[15635247]
NPO8076 Viburnum luzonicum Species Adoxaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO8076 Viburnum luzonicum Species Adoxaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 3390.0 nM PMID[490340]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC251062 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC184464
0.9781 High Similarity NPC186296
0.9779 High Similarity NPC154262
0.9779 High Similarity NPC137501
0.9779 High Similarity NPC7518
0.9779 High Similarity NPC159387
0.9507 High Similarity NPC96599
0.9489 High Similarity NPC49597
0.9441 High Similarity NPC240592
0.9441 High Similarity NPC117346
0.9429 High Similarity NPC296659
0.9429 High Similarity NPC202391
0.9353 High Similarity NPC46644
0.9241 High Similarity NPC289021
0.9241 High Similarity NPC158546
0.922 High Similarity NPC237872
0.922 High Similarity NPC302286
0.922 High Similarity NPC263397
0.922 High Similarity NPC116104
0.922 High Similarity NPC88754
0.9122 High Similarity NPC475484
0.911 High Similarity NPC475379
0.906 High Similarity NPC475378
0.9028 High Similarity NPC37838
0.9021 High Similarity NPC478240
0.8978 High Similarity NPC254819
0.8973 High Similarity NPC478234
0.8973 High Similarity NPC478236
0.8966 High Similarity NPC18789
0.8936 High Similarity NPC220936
0.8936 High Similarity NPC31745
0.8921 High Similarity NPC169398
0.8919 High Similarity NPC194705
0.8912 High Similarity NPC147224
0.8859 High Similarity NPC229354
0.8851 High Similarity NPC269914
0.8851 High Similarity NPC478249
0.8819 High Similarity NPC293154
0.8816 High Similarity NPC179914
0.8808 High Similarity NPC478248
0.8792 High Similarity NPC478235
0.8784 High Similarity NPC35097
0.8776 High Similarity NPC308178
0.8767 High Similarity NPC473147
0.8767 High Similarity NPC119773
0.8767 High Similarity NPC474268
0.8767 High Similarity NPC475539
0.8767 High Similarity NPC143246
0.8759 High Similarity NPC194938
0.8759 High Similarity NPC63304
0.8733 High Similarity NPC229548
0.8733 High Similarity NPC89693
0.8733 High Similarity NPC478241
0.8732 High Similarity NPC65262
0.8732 High Similarity NPC101686
0.8732 High Similarity NPC469364
0.871 High Similarity NPC109990
0.8705 High Similarity NPC478255
0.8705 High Similarity NPC475824
0.8699 High Similarity NPC475528
0.869 High Similarity NPC475213
0.869 High Similarity NPC152796
0.8686 High Similarity NPC106677
0.8675 High Similarity NPC478232
0.8662 High Similarity NPC472132
0.8649 High Similarity NPC120728
0.8645 High Similarity NPC145847
0.863 High Similarity NPC473281
0.863 High Similarity NPC77922
0.8621 High Similarity NPC296643
0.8613 High Similarity NPC267733
0.8613 High Similarity NPC276047
0.8609 High Similarity NPC257847
0.8582 High Similarity NPC470143
0.8582 High Similarity NPC322503
0.8571 High Similarity NPC46137
0.8571 High Similarity NPC235294
0.8551 High Similarity NPC471881
0.8551 High Similarity NPC288416
0.8551 High Similarity NPC45224
0.8551 High Similarity NPC35288
0.8551 High Similarity NPC173150
0.8551 High Similarity NPC156692
0.8551 High Similarity NPC471882
0.8533 High Similarity NPC69367
0.8516 High Similarity NPC130489
0.8516 High Similarity NPC478265
0.8516 High Similarity NPC138993
0.8516 High Similarity NPC208676
0.8514 High Similarity NPC212808
0.8514 High Similarity NPC320734
0.8506 High Similarity NPC329997
0.8491 Intermediate Similarity NPC21956
0.8489 Intermediate Similarity NPC225307
0.8478 Intermediate Similarity NPC252114
0.8478 Intermediate Similarity NPC471157
0.8478 Intermediate Similarity NPC61181
0.8477 Intermediate Similarity NPC77310
0.8477 Intermediate Similarity NPC474620
0.8467 Intermediate Similarity NPC161955
0.8467 Intermediate Similarity NPC145287
0.8456 Intermediate Similarity NPC52097
0.8456 Intermediate Similarity NPC473149
0.844 Intermediate Similarity NPC281798
0.844 Intermediate Similarity NPC138777
0.844 Intermediate Similarity NPC246869
0.844 Intermediate Similarity NPC225384
0.8435 Intermediate Similarity NPC204644
0.8429 Intermediate Similarity NPC253595
0.8421 Intermediate Similarity NPC203664
0.8417 Intermediate Similarity NPC175333
0.8417 Intermediate Similarity NPC103533
0.8414 Intermediate Similarity NPC321184
0.8414 Intermediate Similarity NPC171134
0.8414 Intermediate Similarity NPC328273
0.8414 Intermediate Similarity NPC321638
0.8408 Intermediate Similarity NPC476011
0.8406 Intermediate Similarity NPC126991
0.8406 Intermediate Similarity NPC83218
0.84 Intermediate Similarity NPC189631
0.8397 Intermediate Similarity NPC269668
0.8397 Intermediate Similarity NPC474936
0.8387 Intermediate Similarity NPC187205
0.8382 Intermediate Similarity NPC11724
0.8366 Intermediate Similarity NPC469699
0.8365 Intermediate Similarity NPC130730
0.8365 Intermediate Similarity NPC301910
0.8333 Intermediate Similarity NPC263829
0.8333 Intermediate Similarity NPC97240
0.8322 Intermediate Similarity NPC254398
0.8322 Intermediate Similarity NPC210330
0.8313 Intermediate Similarity NPC208818
0.8311 Intermediate Similarity NPC478250
0.8309 Intermediate Similarity NPC476872
0.8298 Intermediate Similarity NPC469549
0.8291 Intermediate Similarity NPC206815
0.8288 Intermediate Similarity NPC81515
0.8288 Intermediate Similarity NPC64141
0.8288 Intermediate Similarity NPC476383
0.8288 Intermediate Similarity NPC68092
0.8288 Intermediate Similarity NPC472350
0.8288 Intermediate Similarity NPC89105
0.8288 Intermediate Similarity NPC197316
0.8278 Intermediate Similarity NPC23677
0.8276 Intermediate Similarity NPC471345
0.8267 Intermediate Similarity NPC474234
0.8264 Intermediate Similarity NPC886
0.8264 Intermediate Similarity NPC34293
0.8264 Intermediate Similarity NPC471883
0.8264 Intermediate Similarity NPC287597
0.8255 Intermediate Similarity NPC196063
0.8255 Intermediate Similarity NPC141455
0.8255 Intermediate Similarity NPC96447
0.8255 Intermediate Similarity NPC296954
0.8255 Intermediate Similarity NPC300894
0.8252 Intermediate Similarity NPC473924
0.8252 Intermediate Similarity NPC473285
0.8243 Intermediate Similarity NPC284957
0.8224 Intermediate Similarity NPC478242
0.8219 Intermediate Similarity NPC476376
0.8219 Intermediate Similarity NPC260425
0.8217 Intermediate Similarity NPC469384
0.8207 Intermediate Similarity NPC476870
0.8205 Intermediate Similarity NPC478266
0.8199 Intermediate Similarity NPC286809
0.8194 Intermediate Similarity NPC28637
0.8188 Intermediate Similarity NPC105005
0.8188 Intermediate Similarity NPC469367
0.8188 Intermediate Similarity NPC40305
0.8182 Intermediate Similarity NPC478268
0.8182 Intermediate Similarity NPC219677
0.8176 Intermediate Similarity NPC476385
0.8176 Intermediate Similarity NPC134405
0.8176 Intermediate Similarity NPC476377
0.8176 Intermediate Similarity NPC47471
0.8175 Intermediate Similarity NPC469548
0.8175 Intermediate Similarity NPC476448
0.8175 Intermediate Similarity NPC476445
0.8169 Intermediate Similarity NPC229784
0.8169 Intermediate Similarity NPC477293
0.8169 Intermediate Similarity NPC295970
0.8169 Intermediate Similarity NPC477294
0.8163 Intermediate Similarity NPC220942
0.8163 Intermediate Similarity NPC205195
0.8158 Intermediate Similarity NPC220282
0.8158 Intermediate Similarity NPC169510
0.8153 Intermediate Similarity NPC475663
0.8153 Intermediate Similarity NPC286919
0.8151 Intermediate Similarity NPC470572
0.8146 Intermediate Similarity NPC229505
0.8137 Intermediate Similarity NPC282551
0.8133 Intermediate Similarity NPC110063
0.8129 Intermediate Similarity NPC232454
0.8129 Intermediate Similarity NPC178449
0.8129 Intermediate Similarity NPC470907
0.8121 Intermediate Similarity NPC140502
0.8121 Intermediate Similarity NPC265648
0.8121 Intermediate Similarity NPC222433
0.8116 Intermediate Similarity NPC469686
0.811 Intermediate Similarity NPC195972

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC251062 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8288 Intermediate Similarity NPD7266 Discontinued
0.8221 Intermediate Similarity NPD7685 Pre-registration
0.7533 Intermediate Similarity NPD6653 Approved
0.7532 Intermediate Similarity NPD1653 Approved
0.7485 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7415 Intermediate Similarity NPD5736 Approved
0.7407 Intermediate Similarity NPD8455 Phase 2
0.7399 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD6190 Approved
0.7368 Intermediate Similarity NPD7097 Phase 1
0.7338 Intermediate Similarity NPD5762 Approved
0.7338 Intermediate Similarity NPD5763 Approved
0.7337 Intermediate Similarity NPD7228 Approved
0.7308 Intermediate Similarity NPD4628 Phase 3
0.7285 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7279 Intermediate Similarity NPD3094 Phase 2
0.7255 Intermediate Similarity NPD4978 Clinical (unspecified phase)
0.7246 Intermediate Similarity NPD7199 Phase 2
0.7241 Intermediate Similarity NPD1091 Approved
0.7239 Intermediate Similarity NPD37 Approved
0.7237 Intermediate Similarity NPD6355 Discontinued
0.723 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.7229 Intermediate Similarity NPD6234 Discontinued
0.7226 Intermediate Similarity NPD6002 Phase 3
0.7226 Intermediate Similarity NPD6004 Phase 3
0.7226 Intermediate Similarity NPD6005 Phase 3
0.7226 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7226 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD6663 Approved
0.7212 Intermediate Similarity NPD4966 Approved
0.7212 Intermediate Similarity NPD4967 Phase 2
0.7212 Intermediate Similarity NPD4965 Approved
0.7193 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7168 Intermediate Similarity NPD6559 Discontinued
0.7162 Intermediate Similarity NPD6362 Approved
0.7152 Intermediate Similarity NPD3764 Approved
0.7143 Intermediate Similarity NPD8127 Discontinued
0.7135 Intermediate Similarity NPD7799 Discontinued
0.7135 Intermediate Similarity NPD3818 Discontinued
0.7124 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7124 Intermediate Similarity NPD5124 Phase 1
0.7123 Intermediate Similarity NPD3092 Approved
0.7117 Intermediate Similarity NPD4380 Phase 2
0.7114 Intermediate Similarity NPD5647 Approved
0.7097 Intermediate Similarity NPD7033 Discontinued
0.7093 Intermediate Similarity NPD7054 Approved
0.7086 Intermediate Similarity NPD8312 Approved
0.7086 Intermediate Similarity NPD8313 Approved
0.7067 Intermediate Similarity NPD2861 Phase 2
0.7066 Intermediate Similarity NPD7075 Discontinued
0.7059 Intermediate Similarity NPD4140 Approved
0.7059 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7052 Intermediate Similarity NPD7074 Phase 3
0.7052 Intermediate Similarity NPD7472 Approved
0.7025 Intermediate Similarity NPD1652 Phase 2
0.7013 Intermediate Similarity NPD5735 Approved
0.7012 Intermediate Similarity NPD7028 Phase 2
0.7 Intermediate Similarity NPD5058 Phase 3
0.7 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.6986 Remote Similarity NPD5126 Approved
0.6986 Remote Similarity NPD5125 Phase 3
0.6981 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6981 Remote Similarity NPD8166 Discontinued
0.6975 Remote Similarity NPD6273 Approved
0.6974 Remote Similarity NPD7095 Approved
0.6971 Remote Similarity NPD7240 Approved
0.6971 Remote Similarity NPD7251 Discontinued
0.6966 Remote Similarity NPD9545 Approved
0.6962 Remote Similarity NPD2424 Discontinued
0.6957 Remote Similarity NPD6685 Approved
0.6951 Remote Similarity NPD7458 Discontinued
0.6932 Remote Similarity NPD7808 Phase 3
0.6932 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6918 Remote Similarity NPD6674 Discontinued
0.6914 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6914 Remote Similarity NPD6797 Phase 2
0.6905 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6886 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6883 Remote Similarity NPD6233 Phase 2
0.6875 Remote Similarity NPD7157 Approved
0.6875 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6863 Remote Similarity NPD3027 Phase 3
0.6849 Remote Similarity NPD3091 Approved
0.6849 Remote Similarity NPD7741 Discontinued
0.6839 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6839 Remote Similarity NPD4060 Phase 1
0.6839 Remote Similarity NPD3620 Phase 2
0.6831 Remote Similarity NPD969 Suspended
0.6829 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6826 Remote Similarity NPD6801 Discontinued
0.6821 Remote Similarity NPD2797 Approved
0.6818 Remote Similarity NPD6798 Discontinued
0.681 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6803 Remote Similarity NPD7503 Approved
0.6797 Remote Similarity NPD4908 Phase 1
0.6795 Remote Similarity NPD230 Phase 1
0.6795 Remote Similarity NPD4340 Discontinued
0.679 Remote Similarity NPD7236 Approved
0.6786 Remote Similarity NPD1358 Approved
0.6783 Remote Similarity NPD7843 Approved
0.6779 Remote Similarity NPD422 Phase 1
0.6779 Remote Similarity NPD3705 Approved
0.677 Remote Similarity NPD3750 Approved
0.6768 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6739 Remote Similarity NPD5738 Clinical (unspecified phase)
0.6739 Remote Similarity NPD5765 Approved
0.6731 Remote Similarity NPD1613 Approved
0.6731 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6727 Remote Similarity NPD5403 Approved
0.6714 Remote Similarity NPD3134 Approved
0.6713 Remote Similarity NPD6912 Phase 3
0.671 Remote Similarity NPD3268 Approved
0.671 Remote Similarity NPD4907 Clinical (unspecified phase)
0.671 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6708 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6689 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6687 Remote Similarity NPD7239 Suspended
0.6686 Remote Similarity NPD7819 Suspended
0.6667 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6667 Remote Similarity NPD1610 Phase 2
0.6667 Remote Similarity NPD4110 Phase 3
0.6647 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6647 Remote Similarity NPD5402 Approved
0.6646 Remote Similarity NPD970 Clinical (unspecified phase)
0.6646 Remote Similarity NPD6353 Approved
0.6646 Remote Similarity NPD5958 Discontinued
0.6645 Remote Similarity NPD8651 Approved
0.6645 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6644 Remote Similarity NPD4198 Discontinued
0.6644 Remote Similarity NPD3095 Discontinued
0.6633 Remote Similarity NPD7930 Approved
0.6632 Remote Similarity NPD7497 Discontinued
0.6632 Remote Similarity NPD7435 Discontinued
0.6627 Remote Similarity NPD1934 Approved
0.6625 Remote Similarity NPD2935 Discontinued
0.662 Remote Similarity NPD2684 Approved
0.6619 Remote Similarity NPD6647 Phase 2
0.6612 Remote Similarity NPD8397 Clinical (unspecified phase)
0.661 Remote Similarity NPD5844 Phase 1
0.661 Remote Similarity NPD8470 Clinical (unspecified phase)
0.6608 Remote Similarity NPD7768 Phase 2
0.6606 Remote Similarity NPD5401 Approved
0.6604 Remote Similarity NPD4538 Approved
0.6604 Remote Similarity NPD4537 Clinical (unspecified phase)
0.6604 Remote Similarity NPD4536 Approved
0.6603 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6597 Remote Similarity NPD8320 Phase 1
0.6597 Remote Similarity NPD8319 Approved
0.6596 Remote Similarity NPD7237 Clinical (unspecified phase)
0.6593 Remote Similarity NPD8434 Phase 2
0.6593 Remote Similarity NPD8150 Discontinued
0.6588 Remote Similarity NPD5761 Phase 2
0.6588 Remote Similarity NPD5760 Phase 2
0.6588 Remote Similarity NPD2393 Clinical (unspecified phase)
0.658 Remote Similarity NPD7585 Approved
0.6579 Remote Similarity NPD5327 Phase 3
0.6577 Remote Similarity NPD1357 Approved
0.6575 Remote Similarity NPD690 Clinical (unspecified phase)
0.6568 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6568 Remote Similarity NPD7411 Suspended
0.6562 Remote Similarity NPD7999 Approved
0.6562 Remote Similarity NPD5588 Approved
0.6562 Remote Similarity NPD1510 Phase 2
0.6561 Remote Similarity NPD4062 Phase 3
0.6558 Remote Similarity NPD4624 Approved
0.6558 Remote Similarity NPD2798 Approved
0.6554 Remote Similarity NPD3751 Discontinued
0.655 Remote Similarity NPD3817 Phase 2
0.6545 Remote Similarity NPD7680 Approved
0.6545 Remote Similarity NPD6799 Approved
0.6543 Remote Similarity NPD1549 Phase 2
0.6536 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6536 Remote Similarity NPD3225 Approved
0.6536 Remote Similarity NPD1876 Approved
0.6534 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6534 Remote Similarity NPD6166 Phase 2
0.6534 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6533 Remote Similarity NPD3019 Approved
0.6533 Remote Similarity NPD2932 Approved
0.6533 Remote Similarity NPD4059 Approved
0.6533 Remote Similarity NPD4626 Approved
0.6528 Remote Similarity NPD7583 Approved
0.6522 Remote Similarity NPD2438 Suspended
0.6522 Remote Similarity NPD3020 Approved
0.6513 Remote Similarity NPD1608 Approved
0.6509 Remote Similarity NPD6599 Discontinued
0.6506 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6503 Remote Similarity NPD5698 Clinical (unspecified phase)
0.65 Remote Similarity NPD6764 Approved
0.65 Remote Similarity NPD6765 Approved
0.6497 Remote Similarity NPD7473 Discontinued
0.6494 Remote Similarity NPD987 Approved
0.6492 Remote Similarity NPD6823 Phase 2
0.649 Remote Similarity NPD3496 Discontinued
0.649 Remote Similarity NPD3847 Discontinued
0.6486 Remote Similarity NPD694 Clinical (unspecified phase)
0.6485 Remote Similarity NPD6667 Approved
0.6485 Remote Similarity NPD6666 Approved
0.6484 Remote Similarity NPD7090 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data